An Open Study To Estimate The Plasma Pharmacokinetics Of PF-04764793 Administered Via Oral Inhalation Using Dry Powder Inhalers

Trial Profile

An Open Study To Estimate The Plasma Pharmacokinetics Of PF-04764793 Administered Via Oral Inhalation Using Dry Powder Inhalers

Completed
Phase of Trial: Phase I

Latest Information Update: 11 May 2011

At a glance

  • Drugs PF 4764793 (Primary)
  • Indications Asthma
  • Focus Pharmacokinetics
  • Most Recent Events

    • 11 May 2011 Actual end date (May 2011) added as reported by ClinicalTrials.gov.
    • 11 May 2011 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
    • 14 Mar 2011 Actual initiation date (Jan 2011) added as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top